Navigation Links
Crannose(TM) Extra Strength Women's Health Formula Targets Urinary Tract Infections
Date:4/1/2008

ORLANDO, Fla., April 1, 2008 /PRNewswire/ -- Valensa International introduced Crannose(TM) Extra Strength Women's Health Formula at this year's Natural Products Expo West Conference. This patent-pending supplement, manufactured using novel CIT technology, combines the historically known benefits of cranberry with D-mannose, a naturally occurring, non-caloric, simple sugar, extracted from the Larch tree. The product is available in bulk, 2-piece capsules, as a beverage pre-mix or beverage sachet formula.

According to Dr. Rudi E. Moerck, President of Valensa, there is a viable and growing market for a natural promoter of urinary tract health that can affect the conditions that lead to urinary tract infections (UTIs). "Antibiotics are the standard drug-based treatment for UTIs, but they often eliminate a woman's 'good' vaginal bacteria in the course of treating the targeted infection. This situation often leads to painful secondary fungal infections like Candida that can themselves require drug treatment. The increased use of antibiotics generally has contributed to antimicrobial resistance, a growing public health concern," he added.

Dual action targets urinary tract health

During UTIs, E. coli bacteria gain a foothold by adhering to the bladder wall and/or urethra, causing infection. Crannose(TM) Extra Strength creates an environment in the bladder that helps prevent bacteria from gaining that foothold. Supplementation with Crannose(TM) Extra Strength helps to acidify the urine, while its anti-adhesion properties naturally prevent bacteria from attaching to the urinary tract lining. It provides an ideal competitive receptor site for the bacteria, creating a "path of least resistance" for it to be excreted quickly and harmlessly.

Crannose(TM) Extra Strength is very slowly metabolized in the body, so that when ingested, it travels directly to the bloodstream from the upper GI tract, and is filtered through the kidneys to the bladder for excretion -- unchanged. Crannose(TM) Extra Strength is a safe, plant-based supplement providing a healthy alternative to cranberry juice products that contain unacceptable quantities of sugar. A daily dose of just two 625 mg capsules of Crannose(TM) Extra Strength is recommended. This dosage should be doubled when a UTI is present.

According to Dr. John Minatelli, Senior Vice President, Business Development, cranberry juice has long been regarded as a preferred aid in the healthy function of the human urinary tract. "Recent studies suggest that the anti-adhesion and antioxidant properties of cranberry juice create conditions that will limit the possibility of a UTI from occurring in the first place. Research has further documented that natural D-mannose has been shown to attach to the fibrils of E. coli even more effectively than cranberry juice," he said. "Crannose(TM) Extra Strength combines the proven efficacy of unsweetened whole cranberry with the scientifically validated effects of D-mannose. This powerful combination significantly improves the anti-adhesion effectiveness over cranberry juice alone. The Crannose(TM) Extra Strength formula greatly enhances the natural D-mannose already present in cranberry, all in one low-calorie package," he added.

For further information, contact:

Sid Hulse, Vice President, Marketing & Sales

Voice: 352-357-2004 ext. 743

Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Valensa International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New study: Pine bark extract reduces ADHD symptoms in children
2. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
3. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
4. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
5. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
6. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
7. Portal vein thrombosis is common in extraportal vein obstruction
8. New study: pine bark extract boosts nitric oxide production
9. Markel Expands Classes for Contagion Risk with OUTBREAK(R) Extra Expense Coverage
10. Broccoli sprout-derived extract protects against ultraviolet radiation
11. Extracts of catfish caught in polluted waters cause breast cancer cells to multiply
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... More than 80 representatives of the Hepatitis B ... Cancer Foundation held an event on National Hepatitis Testing Day outside of Philadelphia City ... the leading cause of liver cancer. , Foundation leaders and the citywide coalition they ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... mix of advanced Artificial Intelligence (AI) and the latest in Clinical Patient ... center is integrating predictive analytic outputs directly into the clinical workflow. These insights ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service to the ... whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander will be ... opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO Miles Adcock ...
(Date:5/31/2016)... ... 31, 2016 , ... In his latest video, renowned AstroNumerologist ... humans. Using presidential candidate Donald Trump as an example, Kalsi describes the way ... not about adding numbers up,” says Kalsi. “It is about looking at each ...
(Date:5/31/2016)... ... 31, 2016 , ... TeaZa® Energy, LLC announces the launch of ... No Tobacco Day . The new flavor—Tropical TeaZa? Energy—will be available to customers ... , The new flavor is best described as a juicy, taste bud takeover. ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 According ... "Medical Waste Management Market - U.S. Industry Analysis, Size, Share, ... management market in the U.S. was valued at US$ 5.89 ... CAGR of 3.4% from 2015 to 2023 to reach US$ ... analysis of current and emerging needle free drug delivery devices ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
(Date:5/26/2016)... Since its commercial introduction in ... life science tool for conducting genetic studies in a ... in its new report that the industry sits on ... by a range of new applications in the clinical ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the Human ...
Breaking Medicine Technology: